Replies to post #37616 on Anavex Life Sciences Corp (AVXL)

[cjstocksup]

Patience the shorts/hedge funds should be done down here. Then they should be doing their third part promos again to run AVXL up HUGE above. They take them down but take them up just as hard.

If the trial was well designed and had great results the stock would be trading at least $40 a share right now.

[XenaLives]

You assume an efficient market - big mistake.

I was an insider on an OTC with great tech for three years. Price bore no relationship to the quality of the tech, may still take a few years for it to be realistic. That was in an emerging market - robotics.

This drug treats diseases that have no really good treatments on the market. It has shown unprecedented early results and the Big Boys want in; they have the power to manipulate the market.

Governments around the world are spending unprecedented sums on caring for an aging population. If this drug works as they appear to work in the recently released trial results Anavex 2-73 will launch like no other drug in history.

[stealthways]

you forgot how complex AD is and how complex the interrelation of the different receptor actions is with a new drug like 273, thats why information gathering quickly (i.e. an open adaptive trial) was used .... nice try though..

[2014turnaround]

Really what was ACAD price in 2011, before the phase 3 results came out! Would you like 50 more examples? How about ANAC at 6.00 in 2011 MR. biotech lol!

[2014turnaround]

Adam F bashed and hated ACAD AT 2.00,he hated AVNR at 3.00 said it was overpriced cough syrup,was bought out for 17.00!